[TLX] QoQ Quarter Result on 30-Jun-2017 [#Q2]

Stock
[TLX] Telix Pharmaceuticals Limited
Announcement Date
29-Jun-2017
Financial Year
2017
Quarter
30-Jun-2017 [#Q2]
Profit Trend
QoQ- -0.96%
YoY-
Quarter Report
TLX's Result
TLX's Financial Summary
View:
Show?
Quarter Result
30/06/18 31/03/18 31/12/17 30/06/17 31/03/17 31/01/17 30/09/00 CAGR
Revenue 49 49 49 0 0 0 0 -
PBT -5,190 -3,928 -4,806 -1,571 -1,594 -1,594 -124 23.40%
Tax -471 -471 -471 -38 -38 -38 -124 7.80%
NP -5,190 -3,457 -4,806 -1,571 -1,556 -1,556 0 -
Tax Rate - - - - - - - -
Total Cost 5,239 3,506 4,854 1,571 1,556 1,556 0 -
Ratio Analysis
30/06/18 31/03/18 31/12/17 30/06/17 31/03/17 31/01/17 30/09/00 CAGR
NP Margin -10,638.53 -7,087.06 -9,850.62 0.00 0.00 0.00 0.00 -
Per Share
30/06/18 31/03/18 31/12/17 30/06/17 31/03/17 31/01/17 30/09/00 CAGR
EPS -0.03 -0.02 -0.02 -0.64 -0.01 -0.01 0.00 -
EPS Diluted -0.03 -0.02 -0.02 -0.64 -0.01 -0.01 0.00 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.